One-Time Gain Helps to Boost Abbott's Profit 53% by Offsetting Lower Sales
One-Time Gain Helps to Boost Abbott's Profit 53% by Offsetting Lower Sales
SUGAR LAND--April 16, 2009--Researched by Industrial Info Resources (Sugar Land, Texas)--Abbott Laboratories (NYSE:ABT) (Abbott Park, Illinois) has announced that it posted a first-quarter 2009 profit of $1.44 billion, up 53.4% compared with $938 million year over year. The increase is attributed to a one-time gain of $505 million after taxes related to a partnership with Japan's Takeda Pharmaceutical Company (TYO:4502) (Osaka). Industrial Info is tracking 12 active Abbott projects in the U.S. worth $172 million combined. The projects range from $1 million maintenance shutdowns to a $150 million grassroot research center.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- México registra inversiones por 2 mil millones de dólares en el sector farm...
- Mexico Registers US$2 Billion in Pharmaceutical Investments
- New England Sees $27 Billion in Projects Under Construction
- Pharma, Manufacturing Lead Indiana to $21.6 Billion of Projects Under Const...
- India Aims to Reduce Dependence on China for Pharma Market